Gaucher Community Alliance During COVID-19 | CheckRare
Aviva Rosenberg of the Gaucher Community Alliance discusses some of the projects her organization is doing to assist the Gaucher disease community during the COVID-19 pandemic.
Aviva Rosenberg of the Gaucher Community Alliance discusses some of the projects her organization is doing to assist the Gaucher disease community during the COVID-19 pandemic.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Judith Luker discusses the sudden unexpected death in epilepsy communication gap and the importance of physician-patient conversations.
Dr. Smith-Whitley, pediatric hematologist at the Children’s Hospital of Philadelphia, discusses the advances in sickle cell disease.
Dr. Varshavsky-Yanovsky discusses the safety of elranatamab in Black or African-American patients with multiple myeloma.
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy.
Alaa Hamed, MD, Global Head of Medical Affairs Rare Diseases at Sanofi, discusses the importance of rare disease registries.
We have noticed an unusual activity from your IP 199.16.157.182 and blocked access to this
Robin Kate Kelley, professor of clinical medicine, University of California, San Francisco, dissects biliary tract cancer.
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
Priya Kishnani, MD, Professor of Pediatrics at Duke University Medical Center, discusses intrauterine treatment for lysosomal diseases.